Efficacy and Safety of Autologous Haematopoietic Stem Cell Transplantation Versus Alemtuzumab, Ocrelizumab, Ofatumumab or Cladribine in Relapsing Remitting Multiple Sclerosis (starms): Protocol for a Randomised Controlled Trial
BMJ OPEN（2024）
Key words
Multiple sclerosis,Randomized Controlled Trial,Clinical trials
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined